October 01, 2018
Targovax presented ONCOS-102 poster at 13th International Adenovirus Meeting
Media
October 01, 2018
Orexo internalizes contract field force in the US to further strengthen the commercial organization
September 28, 2018
Altimmune Announces Pricing of $12 Million Underwritten Public Offering
September 27, 2018
Targovax to Host Key Opinion Leader Symposium on Oncolytic Viruses in New York City, 11 October 2018
September 27, 2018
Targovax announces interim results from Phase I trial of ONCOS-102 in checkpoint inhibitor refractory melanoma
September 26, 2018
Vicore Pharma postpones publication of interim report
September 24, 2018
Altimmune Announces $4.9 million Registered Direct Offering of Common Stock
September 24, 2018
Altimmune Awarded $2.5 Million in Additional BARDA Funding to Support NasoShield™ Development
September 19, 2018
BONESUPPORT highlights significant strategic progress at Capital Market Days in Stockholm and London
September 18, 2018
Strongbridge Biopharma plc to Participate in Two Upcoming Healthcare Investor Conferences
